29-30 April 2025

Burlington, MA, USA

With over 430 biotech companies registered in Massachusetts alone, the New England region is home to not only industry heavyweights and household names, but start-ups at the leading edge of drug discovery and the medical technologies of the future.  COG New England brings together senior decision-makers from across the spectrum of New England and wider East Coast-based, trial sponsors to hear from thought leaders within the industry, regulators and academia alongside a group of the most trusted and innovative solution providers.